History

This section contains detailed information with key events on the history of the development of AVVA RUS JSC from the date of its creation to the present.
28
years of successful work in the pharmaceutical market
20
20
AVVA RUS has successfully passed an audit by the Saudi FDA for compliance with GMP standards
20
18

AVVA RUS JSC received the European GMP EU certificate.

AVVA RUS JSC concluded an agreements for supplying of products in Mongolia.

AVVA RUS started the registration of medicine in Turkmenistan.

The drug Ecofuril received the Green Cross International Pharmaceutical Award in the nomination “Balance in the treatment of diarrhea and restoration of microflora”.

Launch of a new packaging line in production.


20
17
AVVA RUS JSC has concluded Agreements with companies in Georgia and Kyrgyzstan for the supplying of medicine.

20
16
AVVA RUS JSC has successfully passed recertification for compliance of the quality management system with the requirements of ISO 9001-2015.

20
15
The line for the production of pellets and powders in sachets was launched.

20
14
Launch of the production of suppositories and liquid dosage forms.


20
13
A strategic marketing agreement was concluded with OJSC Farmstandart on joint promotion of the medical products like Micrazim, Lactofiltrum, Filtrum, Ursoliv, Dinolac on the Russian market.
20
12
Medical drug Ursoliv and ecoantibiotic were started to market in the Russian Federation and in the CIS.

20
10
Pharmaceutical company AVVA RUS was founded. Both AVVA RUS and the Swiss company AVVA Pharmaceutical AG are included in the group. The company AVVA Ukraine and the representative office in the Republic of Uzbekistan AVVA Uzbekistan were established.

20
06
Beginning of cooperation with AVVA Pharmaceuticals AG on development and registration of ecoantibiotics. An R&D laboratory for new medical products was established.

20
05

Technological lines for the production of various forms of medical products are being created.

Tablet production is expanding. The production of branded products "Filtrum" and "Lactofiltrum" is being established.

Launching the production of betalactam antibiotics.

20
02

Creation of pharmaceutical group Leksir comprising:

  • Leksir – engineering and marketing company which is also the group managing company (located in Moscow);
  • Leksir Ukraine – the representative office.


20
00

Creation of a technological line for the production of various forms of medical products.

STI-MED-SORB begins modernization and reconstruction of the enterprise to GMP standards.

19
99

The first drugs produced under its own brand name were Polyphepan and Polyphan enteric sorbents based on hydrolysis lignin. At the same time, the company is developing a new line of business: the supply of imported substances to plants along with scientific and technological documentation and know-how.

19
96

Establishment of the pharmaceutical company "Sti-Medsorb" in Kirov. Development of the production of hydrolytic lignin substance and finished dosage forms based on it at the STI-MED-SORB plant, Kirov. Lignin is a natural enterosorbent that can effectively remove harmful toxins from the body.

AVVA today